Freenome ^Company

Founded in 2014 in South San Francisco, California, Freenome is a biotechnology company developing multi-omics blood tests for the early detection of cancer. Its platform integrates genomics, epigenomics, transcriptomics, and proteomics with machine learning. Freenome’s lead programs target colorectal cancer screening, with broader applications in early oncology diagnostics. (freenome.com)